These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14687065)

  • 21. The impact of the factor V Leiden mutation on pregnancy.
    Spina V; Aleandri V; Morini F
    Hum Reprod Update; 2000; 6(3):301-6. PubMed ID: 10874575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined heterozygosity for methylenetetrahydrofolate reductase (MTHFR) mutations C677T and A1298C is associated with abruptio placentae but not with intrauterine growth restriction.
    Gebhardt GS; Scholtz CL; Hillermann R; Odendaal HJ
    Eur J Obstet Gynecol Reprod Biol; 2001 Aug; 97(2):174-7. PubMed ID: 11451544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of maternal and/or fetal factor V Leiden and G20210A prothrombin mutation with HELLP syndrome and intrauterine growth restriction.
    Schlembach D; Beinder E; Zingsem J; Wunsiedler U; Beckmann MW; Fischer T
    Clin Sci (Lond); 2003 Sep; 105(3):279-85. PubMed ID: 12725641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase gene mutations in patients with severe pregnancy complications in northern Finland.
    Jarvenpaa J; Pakkila M; Savolainen ER; Perheentupa A; Jarvela I; Ryynanen M
    Gynecol Obstet Invest; 2006; 62(1):28-32. PubMed ID: 16514238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies.
    de Vries JI; Dekker GA; Huijgens PC; Jakobs C; Blomberg BM; van Geijn HP
    Br J Obstet Gynaecol; 1997 Nov; 104(11):1248-54. PubMed ID: 9386024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Factor V Leiden mutation and pregnancy complications].
    Abraitis V; Mongirdiene A; Mockeviciene A
    Medicina (Kaunas); 2003; 39(9):823-9. PubMed ID: 14515043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombophilias and adverse pregnancy outcome - A confounded problem!
    Kist WJ; Janssen NG; Kalk JJ; Hague WM; Dekker GA; de Vries JI
    Thromb Haemost; 2008 Jan; 99(1):77-85. PubMed ID: 18217138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thrombophilic mutation by women with serious pregnancy complications].
    Vavrinková B; Binder T; Hadacová I; Hrachovinová I; Salaj P; Hruda M
    Ceska Gynekol; 2012 Apr; 77(2):171-4. PubMed ID: 22702078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple obstetric complications of factor V Leiden mutation.
    Tuohy J
    Aust N Z J Obstet Gynaecol; 2000 May; 40(2):203-4. PubMed ID: 10925911
    [No Abstract]   [Full Text] [Related]  

  • 30. Genetic hypofibrinolysis in complicated pregnancies.
    Glueck CJ; Kupferminc MJ; Fontaine RN; Wang P; Weksler BB; Eldor A
    Obstet Gynecol; 2001 Jan; 97(1):44-8. PubMed ID: 11152905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pregnancy outcomes in a patient-heterozygous carrier of R506Q mutation of factor V (Leiden)].
    Herman M; Djelmis J; Troselj Z; Ivanisević M
    Acta Med Croatica; 2006 Jun; 60(3):277-80. PubMed ID: 16933843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double inherited thrombophilias and adverse pregnancy outcomes: fashion or science?
    Larciprete G; Rossi F; Deaibess T; Brienza L; Barbati G; Romanini E; Gioia S; Cirese E
    J Obstet Gynaecol Res; 2010 Oct; 36(5):996-1002. PubMed ID: 20868443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombophilic mutations are a main risk factor for placental abruption.
    Facchinetti F; Marozio L; Grandone E; Pizzi C; Volpe A; Benedetto C
    Haematologica; 2003 Jul; 88(7):785-8. PubMed ID: 12857557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low birthweight in relation to placental abruption and maternal thrombophilia status.
    Nath CA; Ananth CV; DeMarco C; Vintzileos AM;
    Am J Obstet Gynecol; 2008 Mar; 198(3):293.e1-5. PubMed ID: 18191809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Normal anticoagulant system and risk of placental abruption: protein C, protein S and resistance to activated protein C.
    Ananth CV; Nath CA; Philipp C;
    J Matern Fetal Neonatal Med; 2010 Dec; 23(12):1377-83. PubMed ID: 20334530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Placental genotyping of the factor V Leiden, prothrombin 20210A and the methylenetetrahydrofolate reductase (MTHFR) C677T alleles in IUGR pregnancies.
    Wisotzkey JD; Bayliss P; Rutherford E; Bell T
    Thromb Haemost; 1999 May; 81(5):844-5. PubMed ID: 10365762
    [No Abstract]   [Full Text] [Related]  

  • 37. [Impact of inherited thrombophilia on the development of some pregnancy complications].
    Koleva R; Dimitrova V; Chernev T; Savov A; Karag'ozova Zh; Mazneŭkova V; Kremenski I
    Akush Ginekol (Sofiia); 2005; 44(5):18-26. PubMed ID: 16313049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in prothrombin and factor V genes do not contribute significantly to placental vasculopathy in a high-risk patient cohort in South Africa.
    Hillermann R; Gebhardt GS; Isaacs R; Steyn DW; Odendaal HJ
    S Afr Med J; 2002 Jul; 92(7):526-7. PubMed ID: 12197192
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of factor V Leiden in maternal health and the outcome of pregnancy.
    Calderwood CJ; Greer IA
    Curr Drug Targets; 2005 Aug; 6(5):567-76. PubMed ID: 16026277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated protein C resistance can be associated with recurrent fetal loss.
    Brenner B; Mandel H; Lanir N; Younis J; Rothbart H; Ohel G; Blumenfeld Z
    Br J Haematol; 1997 Jun; 97(3):551-4. PubMed ID: 9207398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.